CRB1 and Retinal dystrophy: We suspect that in the pathological settings of AMD, retinal dystrophies and human diseases involving different CRB1 mutations (for example, Lebers congenital amaurosis, and childhood-onset dystrophies), the level of activation of subretinal MG/MΦ increases significantly.